Literature DB >> 10993489

The two faces of Alzheimer's disease.

W A van Gool1, P Eikelenboom.   

Abstract

Correct classification of patients with dementia is pertinent to proper interpretation of research findings. However, the history of Alzheimer's disease (AD) is characterized by a continuing debate on its nosological status. Cerebrovascular pathology, Lewy bodies, or hippocampal sclerosis in combination with neuropathological signs of AD of only limited severity results in a disease that is essentially different from severe, purely degenerative AD. The clinical signs, course of the disease, and pathological correlates in elderly patients suffering from "mixed dementia of the Alzheimer type," may differ from those with "purely degenerative Alzheimer's disease" as encountered in relatively young patients. Both clinicians and researchers have much to gain from a perspective that acknowledges the differences between these subgroups of AD patients. It may provide a more realistic perspective, and it holds promise for new opportunities for prevention and treatment.

Entities:  

Mesh:

Year:  2000        PMID: 10993489     DOI: 10.1007/s004150070147

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  4 in total

1.  Alzheimer's disease--one clinical syndrome, two radiological expressions: a study on blood pressure.

Authors:  F-E De Leeuw; F Barkhof; P Scheltens
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-09       Impact factor: 10.154

2.  Adaptive cognitive testing in dementia.

Authors:  Hans Wouters; Aeilko H Zwinderman; Willem A van Gool; Ben Schmand; Robert Lindeboom
Journal:  Int J Methods Psychiatr Res       Date:  2009-06       Impact factor: 4.035

3.  Neuroinflammation in Alzheimer's disease wanes with age.

Authors:  Jeroen J M Hoozemans; Annemieke J M Rozemuller; Elise S van Haastert; Piet Eikelenboom; Willem A van Gool
Journal:  J Neuroinflammation       Date:  2011-12-07       Impact factor: 8.322

Review 4.  A review of β-amyloid neuroimaging in Alzheimer's disease.

Authors:  Paul A Adlard; Bob A Tran; David I Finkelstein; Patricia M Desmond; Leigh A Johnston; Ashley I Bush; Gary F Egan
Journal:  Front Neurosci       Date:  2014-10-31       Impact factor: 4.677

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.